Demonstrating clinical efficacy and healthcare resource utilization reduction in post-launch populations.
Payors increasingly tie PDTx reimbursement to verified patient outcomes. DTxSystem correlates daily therapy adherence with reductions in emergency room visits, HbA1c levels, or prescription opioid usage.
De-identified population health dashboards allow health system medical directors to monitor clinical outcomes across thousands of enrolled patients in real time while preserving patient privacy.